Entering text into the input field will update the search result below

FDA OKs Lannett's generic cyproheptadine hydrochloride syrup

Jul. 14, 2017 7:29 AM ETLannett Company, Inc. (LCINQ) StockBy: Douglas W. House, SA News Editor5 Comments
  • The FDA approves Lannett Company's (NYSE:LCI) Abbreviated New Drug Application (ANDA) for its generic version of Lyne Laboratories' Cyproheptadine Hydrochloride Syrup for the symptomatic treatment of allergic reactions.
  • The original branded product, Periactin Syrup, was marketed by Merck.
  • The U.S. wholesale market is ~$6M.

Recommended For You

Related Stocks

SymbolLast Price% Chg
LCINQ--
Lannett Company, Inc.